Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis

Tumor Biology

Volumn 35, Issue 12, 2014, Pages 11771-11779

  Sun, G G ^a   Lu, Y F ^b   Cheng, Y J ^c   Yang, C R ^c   Liu, Q ^c   Jing, S W ^c   Han, X C ^a  

^a TANGSHAN PEOPLE S HOSPITAL   (China)

^b Tangshan Workers Hospital   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Bcl 2; BTG1; CND1; Hepatocellular carcinoma; Metastasis; MMP 9

Indexed keywords

B CELL TRANSLOCATION GENE 1 PROTEIN; CYCLIN D1; GELATINASE B; PROTEIN; PROTEIN BCL 2; UNCLASSIFIED DRUG; BTG1 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; HEPG2 CELL LINE; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; WESTERN BLOTTING; AGED; CANCER GRADING; CELL MOTION; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

ADULT; AGED; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; TRANSFECTION;

EID: 84925283726     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2298-x     Document Type: Article

References (18)

1. Okuyama T, Maehara Y, Kabashima A, et al. Combined evaluation of expressions of p53 and p21 proteins as prognostic factors for patients with gastric carcinoma. Oncology. 2002;63:353–61.
2. Cortes U, Moyret-Lalle C, Falette N, et al. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage. Mol Carcinog. 2000;27:57–64.
3. Winkler GS. The mammalian anti-proliferative BTG/Tob protein family. J Cell Physiol. 2010;222:66–72.
4. Rouault JP, Rimokh R, Tessa C, et al. BTG1, a member of a new family of antiproliferative genes. EMBO J. 1992;11:1663–70.
5. Matsuda S, Rouault J, Magaud J, et al. In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett. 2001;497:67–72.
6. Rouault JP, Falette N, Guéhenneux F, et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet. 1996;14:482–6.
7. Zhu R, Zou ST, Wan JM, et al. BTG1 inhibits breast cancer cell growth through induction of cell cycle arrest and apoptosis. Oncol Rep. 2013;30:2137–44.
8. Pramesh CS, Mistry RC, Jambhekar NA, et al. Does the TNM staging system for esophageal cancer need revision? J Am Coll Surg. 2006;202:855–6.
9. Martinez-Outschoorn UE, Pavlides S, Sotgia F, et al. Mitochondrial biogenesis drives tumor cell proliferation. Am J Pathol. 2011;178:1949–52.
10. Koff A, Cross F, Fisher A, et al. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell. 1991;66:1217–28.
11. Kwon TK, Nordin AA. Overexpression of cyclin E and cyclin dependent kinase inhibitor p27kip1 Effect on cell cycle regulation in Hela cell. Biochem Biophys Res Commun. 1997;238:534–8.
12. Nicholson DW, Thornberry NA. Apoptosis. Life and death decisions. Science. 2003;299:214–5.
13. Tirone F. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol. 2001;187:155–65.
14. Corjay MH, Kearney MA, Munzer DA, et al. Antiproliferative gene BTG1 is highly expressed in apoptotic cells in macrophage-rich areas of advanced lesions in Watanabe heritable hyperlipidemic rabbit and human. Lab Investig. 1998;78:847–58.
15. Lee H, Cha S, Lee MS, et al. Role of antiproliferative B cell translocation gene-1 as an apoptotic sensitizer in activation-induced cell death of brain microglia. J Immunol. 2003;171:5802–11.
16. Nahta R, Yuan LX, Fiterman DJ, et al. B cell translocation gene 1 contributes to antisense Bcl-2-mediated apoptosis in breast cancer cells. Mol Cancer Ther. 2006;5:1593–601.
17. Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science. 2002;296:1046–9.
18. Bharti AC, Aggarwal BB. Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol. 2002;64:883–8.